Controlled Substances: Federal CSA and Connecticut Overlay
Federal foundation, state overlay
Connecticut's schedules mirror the federal CSA, but Connecticut adds its own registration, its own reporting duties, and its own enforcement through DCP. Practically, every controlled substance question has two layers.
Schedule II
No refills. The prescription must be written or electronically transmitted, with a narrow emergency-oral exception requiring a written follow-up within seven days. Partial fills are permitted, with the remainder supplied within the federal window; long-term care and terminally ill patients get a longer window. Purchases require DEA Form 222 or CSOS, and a power of attorney allows an agent to sign for Schedule II acquisitions.
Schedules III–V
Up to five refills within six months of the date of issue, whichever comes first. Oral orders are permitted.
Monitoring program
The Connecticut Prescription Monitoring Program is administered by DCP. Dispensers submit dispensing data on a short cycle (generally by the next business day), and prescribers and pharmacists query the system; mandatory-review triggers and delegate accounts exist. Data is confidential and use is restricted.
Losses and records
Theft or significant loss requires written notice to DEA (Form 106) and to the state. Invoices, 222 forms, inventories, and dispensing records must be maintained and retrievable.
Traps
- Applying five refills to a Schedule II drug.
- Assuming a Connecticut schedule differs from the federal schedule.
- Forgetting the separate state registration.
- Treating the PMP as optional rather than a documented clinical step.
Rule of thumb: CII = one fill; CIII–V = five refills or six months, whichever ends first.
Worked example: a Schedule III prescription issued January 5 marked "refill 5 times." The final refill must occur no later than July 4, even if refills remain unused.